Your browser doesn't support javascript.
loading
High dose osimertinib in patients with advanced stage EGFR exon 20 mutation-positive NSCLC: Results from the phase 2 multicenter POSITION20 trial.
Zwierenga, Fenneke; van Veggel, Bianca; Hendriks, Lizza E L; Hiltermann, T Jeroen N; Hiddinga, Birgitta I; Hijmering Kappelle, Lucie B M; Ter Elst, Arja; Hashemi, Sayed M S; Dingemans, Anne-Marie C; van der Leest, Cor; de Langen, Adrianus J; van den Heuvel, Michel M; van der Wekken, Anthonie J.
Afiliação
  • Zwierenga F; Department of Pulmonary Medicine, University of Groningen, University Medical Center Groningen, Groningen, The Netherlands. Electronic address: f.zwierenga@umcg.nl.
  • van Veggel B; Department of Thoracic Oncology, Netherlands Cancer Institute-Antoni van Leeuwenhoek Hospital, Amsterdam, The Netherlands.
  • Hendriks LEL; Department of Respiratory Medicine, Maastricht University Medical Centre, GROW School for Oncology and Developmental Biology, Maastricht, the Netherlands.
  • Hiltermann TJN; Department of Pulmonary Medicine, University of Groningen, University Medical Center Groningen, Groningen, The Netherlands.
  • Hiddinga BI; Department of Pulmonary Medicine, University of Groningen, University Medical Center Groningen, Groningen, The Netherlands.
  • Hijmering Kappelle LBM; Department of Pulmonary Medicine, University of Groningen, University Medical Center Groningen, Groningen, The Netherlands.
  • Ter Elst A; Department of Pathology and Molecular Biology, University of Groningen, University Medical Center Groningen, Groningen, The Netherlands.
  • Hashemi SMS; Department of Pulmonary Diseases, Amsterdam UMC, VU University Medical Center, Amsterdam, The Netherlands.
  • Dingemans AC; Department of Pulmonary Diseases, Erasmus MC Cancer Institute Medical Center, Rotterdam, the Netherlands.
  • van der Leest C; Department of Pulmonology, Amphia Hospital, Breda, The Netherlands.
  • de Langen AJ; Department of Thoracic Oncology, Netherlands Cancer Institute-Antoni van Leeuwenhoek Hospital, Amsterdam, The Netherlands.
  • van den Heuvel MM; Department of Pulmonary Diseases, Radboud University Medical Center, Nijmegen, The Netherlands.
  • van der Wekken AJ; Department of Pulmonary Medicine, University of Groningen, University Medical Center Groningen, Groningen, The Netherlands.
Lung Cancer ; 170: 133-140, 2022 08.
Article em En | MEDLINE | ID: mdl-35777160
Assuntos
Palavras-chave
Texto completo
Adicionar na Minha BVS
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Contexto em Saúde: 3_ND Problema de saúde: 3_diarrhea Assunto principal: Carcinoma Pulmonar de Células não Pequenas / Neoplasias Pulmonares / Antineoplásicos Tipo de estudo: Clinical_trials Limite: Aged / Female / Humans / Male Idioma: En Revista: Lung Cancer Assunto da revista: NEOPLASIAS Ano de publicação: 2022 Tipo de documento: Article
Texto completo
Adicionar na Minha BVS
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Contexto em Saúde: 3_ND Problema de saúde: 3_diarrhea Assunto principal: Carcinoma Pulmonar de Células não Pequenas / Neoplasias Pulmonares / Antineoplásicos Tipo de estudo: Clinical_trials Limite: Aged / Female / Humans / Male Idioma: En Revista: Lung Cancer Assunto da revista: NEOPLASIAS Ano de publicação: 2022 Tipo de documento: Article